Technology

HiFiBiO Therapeutics: Pioneering Curative Immunotherapies

Published

About this Series

Live From MarketSite

With Kristina Ayanian

Nasdaq Listings Host Kristina Ayanian delves into companies' notable accomplishments, industry trends, and the driving factors behind their success through engaging conversations with C-suite executives and industry leaders.


Liang Schweizer, Founder, Chairperson and CEO of HiFiBiO Therapeutics, sits down with Nasdaq Host, Kristina Ayanian, to discuss how the company's single-cell analytics platform is designed to mobilize the human immune system to combat cancer and autoimmune disorders.

More in this Series

See all

Nasdaq Watch

See what's playing at Nasdaq

Watch Now